nodes	percent_of_prediction	percent_of_DWPC	metapath
Haloperidol—EBP—refractive error	0.94	1	CbGaD
Haloperidol—DRD4—Signaling by GPCR—WNT10A—refractive error	6.49e-05	0.00109	CbGpPWpGaD
Haloperidol—DRD2—GPCR downstream signaling—VIPR2—refractive error	6.41e-05	0.00107	CbGpPWpGaD
Haloperidol—ABCB1—Allograft Rejection—PDGFRA—refractive error	6.41e-05	0.00107	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	6.38e-05	0.00107	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PCCA—refractive error	6.38e-05	0.00107	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CHN1—refractive error	6.38e-05	0.00107	CbGpPWpGaD
Haloperidol—HTR2A—GPCR downstream signaling—VIPR2—refractive error	6.31e-05	0.00106	CbGpPWpGaD
Haloperidol—HRH1—GPCR downstream signaling—VIPR2—refractive error	6.3e-05	0.00106	CbGpPWpGaD
Haloperidol—CYP1A2—Biological oxidations—CYP26A1—refractive error	6.25e-05	0.00105	CbGpPWpGaD
Haloperidol—HTR2B—Signaling by GPCR—WNT10A—refractive error	6.2e-05	0.00104	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—OR2M7—refractive error	6.18e-05	0.00104	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—EBP—refractive error	6.16e-05	0.00103	CbGpPWpGaD
Haloperidol—CYP1A2—Metapathway biotransformation—CYP26A1—refractive error	6.16e-05	0.00103	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—OR2M7—refractive error	6.05e-05	0.00101	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—EBP—refractive error	6.02e-05	0.00101	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CHN1—refractive error	6.01e-05	0.00101	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—OR2M7—refractive error	5.95e-05	0.000997	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CHN1—refractive error	5.93e-05	0.000994	CbGpPWpGaD
Haloperidol—DRD1—Signaling by GPCR—WNT10A—refractive error	5.85e-05	0.000979	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—VIPR2—refractive error	5.82e-05	0.000976	CbGpPWpGaD
Haloperidol—DRD3—Signaling by GPCR—WNT10A—refractive error	5.77e-05	0.000966	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—VIPR2—refractive error	5.73e-05	0.00096	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—VIPR2—refractive error	5.72e-05	0.000958	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—OR2M7—refractive error	5.68e-05	0.000952	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—DSE—refractive error	5.55e-05	0.00093	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—OR2M7—refractive error	5.36e-05	0.000898	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—GREM2—refractive error	5.34e-05	0.000895	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—PML—refractive error	5.31e-05	0.00089	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—OR2M7—refractive error	5.29e-05	0.000886	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VIPR2—refractive error	5.25e-05	0.00088	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—GREM2—refractive error	5.25e-05	0.00088	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—GREM2—refractive error	5.24e-05	0.000878	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	5.22e-05	0.000875	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PCCA—refractive error	5.22e-05	0.000875	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VIPR2—refractive error	5.14e-05	0.000862	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VIPR2—refractive error	5.06e-05	0.000848	CbGpPWpGaD
Haloperidol—EBP—Metabolism of lipids and lipoproteins—PTEN—refractive error	5e-05	0.000837	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PLA2G16—refractive error	4.95e-05	0.000829	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PCCA—refractive error	4.95e-05	0.000829	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—RDH5—refractive error	4.94e-05	0.000828	CbGpPWpGaD
Haloperidol—CBR1—Metabolism of lipids and lipoproteins—PTEN—refractive error	4.92e-05	0.000824	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—RDH5—refractive error	4.84e-05	0.00081	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VIPR2—refractive error	4.83e-05	0.00081	CbGpPWpGaD
Haloperidol—CYP3A4—Biological oxidations—CYP26A1—refractive error	4.82e-05	0.000808	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	4.76e-05	0.000798	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PCCA—refractive error	4.76e-05	0.000798	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—RDH5—refractive error	4.76e-05	0.000797	CbGpPWpGaD
Haloperidol—CYP3A4—Metapathway biotransformation—CYP26A1—refractive error	4.75e-05	0.000796	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—AXL—refractive error	4.68e-05	0.000784	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—DSE—refractive error	4.67e-05	0.000782	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—AXL—refractive error	4.58e-05	0.000768	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VIPR2—refractive error	4.56e-05	0.000763	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—RDH5—refractive error	4.54e-05	0.000761	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CHN1—refractive error	4.54e-05	0.000761	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—AXL—refractive error	4.51e-05	0.000756	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VIPR2—refractive error	4.5e-05	0.000753	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CHN1—refractive error	4.47e-05	0.000748	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CHN1—refractive error	4.46e-05	0.000747	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—EBP—refractive error	4.45e-05	0.000746	CbGpPWpGaD
Haloperidol—DRD2—Signaling by GPCR—WNT10A—refractive error	4.41e-05	0.00074	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—refractive error	4.36e-05	0.00073	CbGpPWpGaD
Haloperidol—HTR2A—Signaling by GPCR—WNT10A—refractive error	4.34e-05	0.000728	CbGpPWpGaD
Haloperidol—HRH1—Signaling by GPCR—WNT10A—refractive error	4.33e-05	0.000726	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—AXL—refractive error	4.31e-05	0.000722	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—RDH5—refractive error	4.28e-05	0.000718	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—VANGL2—refractive error	4.28e-05	0.000718	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—RDH5—refractive error	4.23e-05	0.000708	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—EBP—refractive error	4.21e-05	0.000705	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—VANGL2—refractive error	4.19e-05	0.000703	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PLA2G16—refractive error	4.16e-05	0.000697	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PCCA—refractive error	4.16e-05	0.000697	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—VANGL2—refractive error	4.13e-05	0.000691	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PCCA—refractive error	4.07e-05	0.000682	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G16—refractive error	4.07e-05	0.000682	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—AXL—refractive error	4.06e-05	0.00068	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—OR2M7—refractive error	4.05e-05	0.000678	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—AXL—refractive error	4.01e-05	0.000671	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—WNT10A—refractive error	3.98e-05	0.000667	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—OR2M7—refractive error	3.98e-05	0.000667	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—OR2M7—refractive error	3.97e-05	0.000666	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—VANGL2—refractive error	3.94e-05	0.00066	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—WNT10A—refractive error	3.9e-05	0.000653	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—WNT10A—refractive error	3.84e-05	0.000643	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—CER1—refractive error	3.74e-05	0.000627	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—RNF111—refractive error	3.74e-05	0.000627	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—TJP2—refractive error	3.74e-05	0.000627	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—VANGL2—refractive error	3.71e-05	0.000622	CbGpPWpGaD
Haloperidol—DRD4—Circadian rythm related genes—PTEN—refractive error	3.71e-05	0.000621	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—CER1—refractive error	3.67e-05	0.000614	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—VANGL2—refractive error	3.67e-05	0.000614	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—TJP2—refractive error	3.67e-05	0.000614	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—RNF111—refractive error	3.67e-05	0.000614	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—WNT10A—refractive error	3.66e-05	0.000614	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—RNF111—refractive error	3.61e-05	0.000604	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—CER1—refractive error	3.61e-05	0.000604	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—TJP2—refractive error	3.61e-05	0.000604	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—WNT10A—refractive error	3.45e-05	0.000579	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—EBP—refractive error	3.44e-05	0.000577	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—RNF111—refractive error	3.44e-05	0.000577	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—CER1—refractive error	3.44e-05	0.000577	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—TJP2—refractive error	3.44e-05	0.000577	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VIPR2—refractive error	3.44e-05	0.000576	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—LUM—refractive error	3.43e-05	0.000575	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—WNT10A—refractive error	3.41e-05	0.000571	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VIPR2—refractive error	3.39e-05	0.000567	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VIPR2—refractive error	3.38e-05	0.000566	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—DSE—refractive error	3.38e-05	0.000566	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—EBP—refractive error	3.36e-05	0.000563	CbGpPWpGaD
Haloperidol—DRD1—Circadian rythm related genes—PTEN—refractive error	3.34e-05	0.000559	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—CACNA1D—refractive error	3.3e-05	0.000553	CbGpPWpGaD
Haloperidol—DRD3—Circadian rythm related genes—PTEN—refractive error	3.29e-05	0.000551	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—RNF111—refractive error	3.25e-05	0.000544	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—CER1—refractive error	3.25e-05	0.000544	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—TJP2—refractive error	3.25e-05	0.000544	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RDH5—refractive error	3.23e-05	0.000542	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—RNF111—refractive error	3.2e-05	0.000537	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—CER1—refractive error	3.2e-05	0.000537	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—TJP2—refractive error	3.2e-05	0.000537	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—DSE—refractive error	3.19e-05	0.000534	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RDH5—refractive error	3.18e-05	0.000533	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RDH5—refractive error	3.18e-05	0.000532	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—EBP—refractive error	3.17e-05	0.000531	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—refractive error	3.16e-05	0.00053	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—EBP—refractive error	3.14e-05	0.000526	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—AXL—refractive error	3.07e-05	0.000514	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—AXL—refractive error	3.02e-05	0.000506	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—AXL—refractive error	3.01e-05	0.000504	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PLA2G16—refractive error	3.01e-05	0.000504	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PCCA—refractive error	3.01e-05	0.000504	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—CYP26A1—refractive error	2.92e-05	0.000489	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—LUM—refractive error	2.88e-05	0.000483	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PLA2G16—refractive error	2.84e-05	0.000476	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PCCA—refractive error	2.84e-05	0.000476	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—COL9A1—refractive error	2.84e-05	0.000475	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—VANGL2—refractive error	2.8e-05	0.00047	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—COL9A1—refractive error	2.78e-05	0.000465	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—CACNA1D—refractive error	2.78e-05	0.000465	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—VANGL2—refractive error	2.76e-05	0.000462	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—VANGL2—refractive error	2.75e-05	0.000461	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—COL9A1—refractive error	2.73e-05	0.000458	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—EBP—refractive error	2.68e-05	0.00045	CbGpPWpGaD
Haloperidol—ABCB1—Transmembrane transport of small molecules—TUBB3—refractive error	2.66e-05	0.000445	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—DSE—refractive error	2.61e-05	0.000437	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—COL9A1—refractive error	2.61e-05	0.000437	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—WNT10A—refractive error	2.61e-05	0.000437	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—WNT10A—refractive error	2.57e-05	0.00043	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—WNT10A—refractive error	2.56e-05	0.000429	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—DSE—refractive error	2.55e-05	0.000427	CbGpPWpGaD
Haloperidol—DRD2—Circadian rythm related genes—PTEN—refractive error	2.52e-05	0.000422	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—COL9A1—refractive error	2.46e-05	0.000412	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—CYP26A1—refractive error	2.45e-05	0.000411	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—RNF111—refractive error	2.45e-05	0.000411	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—CER1—refractive error	2.45e-05	0.000411	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—TJP2—refractive error	2.45e-05	0.000411	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—COL9A1—refractive error	2.43e-05	0.000407	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—CER1—refractive error	2.41e-05	0.000404	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—RNF111—refractive error	2.41e-05	0.000404	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—TJP2—refractive error	2.41e-05	0.000404	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—RNF111—refractive error	2.41e-05	0.000403	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—CER1—refractive error	2.41e-05	0.000403	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—TJP2—refractive error	2.41e-05	0.000403	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—DSE—refractive error	2.4e-05	0.000402	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—DSE—refractive error	2.38e-05	0.000399	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PCCA—refractive error	2.33e-05	0.00039	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PLA2G16—refractive error	2.33e-05	0.00039	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PLA2G16—refractive error	2.27e-05	0.00038	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PCCA—refractive error	2.27e-05	0.00038	CbGpPWpGaD
Haloperidol—EBP—Metabolism—PTEN—refractive error	2.23e-05	0.000373	CbGpPWpGaD
Haloperidol—CBR1—Metabolism—PTEN—refractive error	2.19e-05	0.000367	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PLA2G16—refractive error	2.14e-05	0.000358	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PCCA—refractive error	2.14e-05	0.000358	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PLA2G16—refractive error	2.12e-05	0.000355	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PCCA—refractive error	2.12e-05	0.000355	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—LUM—refractive error	2.09e-05	0.000349	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—EBP—refractive error	2.07e-05	0.000347	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—DSE—refractive error	2.03e-05	0.000341	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CACNA1D—refractive error	2.01e-05	0.000336	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—LUM—refractive error	1.97e-05	0.00033	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—BMP2—refractive error	1.94e-05	0.000326	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—BMP2—refractive error	1.9e-05	0.000319	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CACNA1D—refractive error	1.9e-05	0.000318	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—BMP2—refractive error	1.87e-05	0.000314	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—COL9A1—refractive error	1.86e-05	0.000311	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—COL9A1—refractive error	1.83e-05	0.000306	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—COL9A1—refractive error	1.82e-05	0.000306	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PLA2G16—refractive error	1.81e-05	0.000304	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PCCA—refractive error	1.81e-05	0.000304	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—BMP2—refractive error	1.79e-05	0.0003	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—CYP26A1—refractive error	1.77e-05	0.000297	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—BMP2—refractive error	1.69e-05	0.000283	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—CYP26A1—refractive error	1.68e-05	0.000281	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—BMP2—refractive error	1.66e-05	0.000279	CbGpPWpGaD
Haloperidol—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—refractive error	1.62e-05	0.000272	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—LUM—refractive error	1.61e-05	0.00027	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—LUM—refractive error	1.57e-05	0.000264	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—DSE—refractive error	1.57e-05	0.000263	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CACNA1D—refractive error	1.55e-05	0.00026	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CACNA1D—refractive error	1.51e-05	0.000254	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—LUM—refractive error	1.48e-05	0.000248	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—refractive error	1.48e-05	0.000248	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—LUM—refractive error	1.47e-05	0.000246	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CACNA1D—refractive error	1.43e-05	0.000239	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CACNA1D—refractive error	1.41e-05	0.000237	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PCCA—refractive error	1.4e-05	0.000234	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PLA2G16—refractive error	1.4e-05	0.000234	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—CYP26A1—refractive error	1.37e-05	0.00023	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—CYP26A1—refractive error	1.34e-05	0.000224	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—BMP2—refractive error	1.27e-05	0.000213	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—CYP26A1—refractive error	1.26e-05	0.000211	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—LUM—refractive error	1.26e-05	0.00021	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—BMP2—refractive error	1.25e-05	0.00021	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—BMP2—refractive error	1.25e-05	0.000209	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—CYP26A1—refractive error	1.25e-05	0.000209	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PDGFRA—refractive error	1.21e-05	0.000203	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CACNA1D—refractive error	1.21e-05	0.000203	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PDGFRA—refractive error	1.19e-05	0.000199	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PDGFRA—refractive error	1.17e-05	0.000196	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PDGFRA—refractive error	1.12e-05	0.000187	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—CYP26A1—refractive error	1.07e-05	0.000179	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PDGFRA—refractive error	1.05e-05	0.000176	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PDGFRA—refractive error	1.04e-05	0.000174	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—LUM—refractive error	9.69e-06	0.000162	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CACNA1D—refractive error	9.33e-06	0.000156	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—refractive error	8.49e-06	0.000142	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—CYP26A1—refractive error	8.24e-06	0.000138	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PDGFRA—refractive error	7.95e-06	0.000133	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PDGFRA—refractive error	7.82e-06	0.000131	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PDGFRA—refractive error	7.8e-06	0.000131	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—refractive error	6.95e-06	0.000116	CbGpPWpGaD
Haloperidol—UGT1A9—Metabolism—PTEN—refractive error	6.58e-06	0.00011	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—refractive error	6.34e-06	0.000106	CbGpPWpGaD
Haloperidol—HTR1D—Signaling Pathways—PTEN—refractive error	6.23e-06	0.000104	CbGpPWpGaD
Haloperidol—HTR1B—Signaling Pathways—PTEN—refractive error	6.1e-06	0.000102	CbGpPWpGaD
Haloperidol—DRD4—Signaling Pathways—PTEN—refractive error	6e-06	0.000101	CbGpPWpGaD
Haloperidol—HTR2B—Signaling Pathways—PTEN—refractive error	5.73e-06	9.6e-05	CbGpPWpGaD
Haloperidol—CYP3A7—Metabolism—PTEN—refractive error	5.54e-06	9.28e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—refractive error	5.41e-06	9.07e-05	CbGpPWpGaD
Haloperidol—DRD1—Signaling Pathways—PTEN—refractive error	5.4e-06	9.05e-05	CbGpPWpGaD
Haloperidol—DRD3—Signaling Pathways—PTEN—refractive error	5.33e-06	8.93e-05	CbGpPWpGaD
Haloperidol—DRD2—Signaling Pathways—PTEN—refractive error	4.08e-06	6.84e-05	CbGpPWpGaD
Haloperidol—HTR2A—Signaling Pathways—PTEN—refractive error	4.01e-06	6.73e-05	CbGpPWpGaD
Haloperidol—HRH1—Signaling Pathways—PTEN—refractive error	4.01e-06	6.71e-05	CbGpPWpGaD
Haloperidol—CYP3A5—Metabolism—PTEN—refractive error	4e-06	6.71e-05	CbGpPWpGaD
Haloperidol—CYP1A1—Metabolism—PTEN—refractive error	3.78e-06	6.34e-05	CbGpPWpGaD
Haloperidol—CYP2C19—Metabolism—PTEN—refractive error	3.09e-06	5.18e-05	CbGpPWpGaD
Haloperidol—ABCB1—Metabolism—PTEN—refractive error	3.02e-06	5.06e-05	CbGpPWpGaD
Haloperidol—CYP2D6—Metabolism—PTEN—refractive error	2.85e-06	4.77e-05	CbGpPWpGaD
Haloperidol—CYP2C9—Metabolism—PTEN—refractive error	2.82e-06	4.73e-05	CbGpPWpGaD
Haloperidol—CYP1A2—Metabolism—PTEN—refractive error	2.41e-06	4.04e-05	CbGpPWpGaD
Haloperidol—CYP3A4—Metabolism—PTEN—refractive error	1.86e-06	3.12e-05	CbGpPWpGaD
